sodium rabeprazole
PolandDrugs containing this active substance
-
The medicine is used for the treatment of, among others, duodenal and gastric ulcers, gastroesophageal reflux disease (with erosions, ulcers, or heartburn), Zollinger-Ellison syndrome, and in combating H. pylori infection (in combination with antibiotics).
Form: tablets, enteric-coated
Active substance Dosage sodium rabeprazole 20 mg ATC: A02BC04
Manufacturer: KRKA, d.d. Novo mesto
-
The medicine is used, among other things, for the treatment of duodenal and gastric ulcers, gastroesophageal reflux disease (with erosions, ulcers, or presenting as heartburn), Zollinger-Ellison syndrome, and H. pylori infection (in combination with antibiotics).
Form: tablets, enteric-coated
Active substance Dosage sodium rabeprazole 20 mg ATC: A02BC04
Manufacturer: KRKA, d.d., Novo mesto
-
The medicine is used, among other things, for the treatment of duodenal and gastric ulcers, gastroesophageal reflux disease (with erosions, ulcers, or heartburn), Zollinger-Ellison syndrome, and to combat H. pylori infection (in combination with antibiotics).
Form: tablets, enteric-coated
Active substance Dosage sodium rabeprazole 10 mg ATC: A02BC04
Manufacturer: Krka, d.d., Novo mesto
-
The medicine is used, among other things, for the treatment of gastric and duodenal ulcers, gastroesophageal reflux disease (with erosions, ulcers, or heartburn), Zollinger-Ellison syndrome, and for combating H. pylori infection (in combination with antibiotics).
Form: tablets, enteric-coated
Active substance Dosage sodium rabeprazole 20 mg ATC: A02BC04
Manufacturer: Krka d.d., Novo mesto
-
The medicine is used for the treatment of, among others, duodenal and gastric ulcers, gastroesophageal reflux disease (GERD) with erosions or ulcers, Zollinger-Ellison syndrome, and in the treatment of H. pylori infection (in combination with antibiotics).
Form: tablets, enteric-coated
Active substance Dosage sodium rabeprazole 10 mg ATC: A02BC04
Manufacturer: Krka d.d., Novo mesto